ARCB (NASDAQ: ARCB) insider files for $1,837,844.17 stock sale

Rhea-AI Filing Summary

A Form 144 notice reports a planned sale of 16,378 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on 02/06/2026 on the NASDAQ exchange, with an aggregate market value of $1,837,844.17.

The shares come from multiple restricted stock awards acquired from the issuer between 2023 and 2025, with full payment marked as not applicable. Shares of this class outstanding total 22,511,021, providing context for the size of the planned sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	16378	1837844.17	22511021	02/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/12/2024	Restricted Stock	Issuer			6798	05/12/2024	Not Applicable
Common	05/06/2024	Restricted Stock	Issuer			543	05/06/2024	Not Applicable
Common	05/07/2025	Restricted Stock	Issuer			400	05/07/2025	Not Applicable
Common	05/05/2025	Restricted Stock	Issuer			669	05/05/2025	Not Applicable
Common	05/11/2024	Restricted Stock	Issuer			1582	05/11/2024	Not Applicable
Common	05/09/2023	Restricted Stock	Issuer			4590	05/09/2023	Not Applicable
Common	05/06/2023	Restricted Stock	Issuer			538	05/06/2023	Not Applicable
Common	05/06/2025	Restricted Stock	Issuer			693	05/06/2025	Not Applicable
Common	05/05/2024	Restricted Stock	Issuer			565	05/05/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ARCB's Form 144 filing report?

The filing reports a planned sale of 16,378 shares of common stock under Rule 144. These shares are expected to be sold on the NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $1,837,844.17.

How many ARCB shares are planned for sale and what is their value?

The notice covers a planned sale of 16,378 common shares with an aggregate market value of $1,837,844.17. This amount is reported alongside class-wide outstanding shares of 22,511,021, indicating the sale represents a small fraction of that class.

When and where are the ARCB shares expected to be sold?

The shares are expected to be sold on or about 02/06/2026 on the NASDAQ exchange. Morgan Stanley Smith Barney LLC Executive Financial Services, based in New York, is listed as the broker handling the planned Rule 144 transaction.

How were the ARCB shares in the Form 144 filing originally acquired?

The shares were acquired as restricted stock directly from the issuer on several dates between 2023 and 2025. Each line item lists an acquisition date, number of shares, and shows the nature of payment as "Not Applicable", indicating no traditional cash purchase.

How many ARCB common shares are outstanding according to the filing?

The filing lists 22,511,021 common shares outstanding for the relevant class of securities. This figure provides a baseline context for assessing the 16,378-share planned sale, showing it is relatively small compared with the total outstanding shares.

What representation does the seller make about nonpublic adverse information?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation also applies as of any Rule 10b5-1 plan adoption date, if applicable.